Correlation Between Cns Pharmaceuticals and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and Altamira Therapeutics, you can compare the effects of market volatilities on Cns Pharmaceuticals and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Altamira Therapeutics.
Diversification Opportunities for Cns Pharmaceuticals and Altamira Therapeutics
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cns and Altamira is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Cns Pharmaceuticals and Altamira Therapeutics
Given the investment horizon of 90 days Cns Pharmaceuticals is expected to generate 1.44 times more return on investment than Altamira Therapeutics. However, Cns Pharmaceuticals is 1.44 times more volatile than Altamira Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Altamira Therapeutics is currently generating about -0.22 per unit of risk. If you would invest 15.00 in Cns Pharmaceuticals on August 28, 2024 and sell it today you would lose (3.00) from holding Cns Pharmaceuticals or give up 20.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cns Pharmaceuticals vs. Altamira Therapeutics
Performance |
| Timeline |
| Cns Pharmaceuticals |
| Altamira Therapeutics |
Cns Pharmaceuticals and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cns Pharmaceuticals and Altamira Therapeutics
The main advantage of trading using opposite Cns Pharmaceuticals and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.| Cns Pharmaceuticals vs. Capricor Therapeutics | Cns Pharmaceuticals vs. Soleno Therapeutics | Cns Pharmaceuticals vs. Bio Path Holdings | Cns Pharmaceuticals vs. Moleculin Biotech |
| Altamira Therapeutics vs. Eliem Therapeutics | Altamira Therapeutics vs. HCW Biologics | Altamira Therapeutics vs. Scpharmaceuticals | Altamira Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |